7-108573269-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012328.3(DNAJB9):āc.588T>Gā(p.Phe196Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,613,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012328.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJB9 | NM_012328.3 | c.588T>G | p.Phe196Leu | missense_variant | 3/3 | ENST00000249356.4 | NP_036460.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJB9 | ENST00000249356.4 | c.588T>G | p.Phe196Leu | missense_variant | 3/3 | 1 | NM_012328.3 | ENSP00000249356 | P1 | |
DNAJB9 | ENST00000465725.1 | n.229+1326T>G | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152166Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250788Hom.: 1 AF XY: 0.0000664 AC XY: 9AN XY: 135576
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461580Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727072
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152166Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2023 | The c.588T>G (p.F196L) alteration is located in exon 3 (coding exon 2) of the DNAJB9 gene. This alteration results from a T to G substitution at nucleotide position 588, causing the phenylalanine (F) at amino acid position 196 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at